Skip to main content
Log in

Dramatic reduction of clindamycin plasma concentration in hidradenitis suppurativa patients treated with the rifampinclindamycin combination

  • Correspondence
  • Published:
European Journal of Dermatology

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

References

  1. Jemec GB. Clinical practice. Hidradenitis suppurativa. N Engl J Med 2012; 366: 158–164.

    Article  CAS  PubMed  Google Scholar 

  2. Gener G, Canoui-Poitrine F, Revuz JE, et al. Combination therapy with clindamycin and rifampicin for hidradenitis suppurativa: a series of 116 consecutive patients. Dermatology 2009; 219: 148–154.

    Article  CAS  PubMed  Google Scholar 

  3. van der Zee HH, Boer J, Prens EP, Jemec GB. The effect of combined treatment with oral clindamycin and oral rifampicin in patients with hidradenitis suppurativa. Dermatology 2009; 219: 143–147.

    Article  PubMed  Google Scholar 

  4. Klein RD, Edberg SC. Applications, significance of, and methods for the measurement of antimicrobial concentrations in human body fluids. In: Lorian V, editor. Antibiotics in laboratory medicine. 5th ed. Baltimore: Lippincott Williams & Wilkins; 2005:290–364.

    Google Scholar 

  5. Niemi M, Backman JT, Fromm MF, Neuvonen PJ, Kivisto KT. Pharmacokinetic interactions with rifampicin: clinical relevance. Clin Pharmacokinet 2003; 42: 819–850.

    Article  CAS  PubMed  Google Scholar 

  6. Wynalda MA, Hutzler JM, Koets MD, Podoll T, Wienkers LC. In vitro metabolism of clindamycin in human liver and intestinal microsomes. Drug Metab Dispos 2003; 31: 878–887.

    Article  CAS  PubMed  Google Scholar 

  7. Zeller V, Dzeing-Ella A, Kitzis MD, Ziza JM, Mamoudy P, Desplaces N. Continuous clindamycin infusion, an innovative approach to treating bone and joint infections. Antimicrob Agents Chemother 2010; 54: 88–92.

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  8. Bouazza N, Pestre V, Jullien V, et al. Population pharmacokinetics of clindamycin orally and intravenously administered in patients with osteomyelitis. Br J Clin Pharmacol 2012; 74: 971–977.

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  9. Join-Lambert O, Guet-Revillet H, Lécuyer H, et al., editors. The Microbiology of Hidradenitis Suppurativa. ICAAC; 2011; Chicago, IL.

    Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Olivier Join-Lambert.

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Join-Lambert, O., Ribadeau-Dumas, F., Jullien, V. et al. Dramatic reduction of clindamycin plasma concentration in hidradenitis suppurativa patients treated with the rifampinclindamycin combination. Eur J Dermatol 24, 94–95 (2014). https://doi.org/10.1684/ejd.2013.2213

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1684/ejd.2013.2213

Keywords

Navigation